Discontinuation of mycophenolate mofetil treatment six months after kidney transplantation.

被引:0
作者
vanGelder, T [1 ]
Yzermans, JNM [1 ]
RischenVos, J [1 ]
Weimar, W [1 ]
机构
[1] UNIV ROTTERDAM HOSP,DEPT INTERNAL MED & SURG 1,ROTTERDAM,NETHERLANDS
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:562 / 562
页数:1
相关论文
共 50 条
  • [41] Limits to Intensified Mycophenolate Mofetil Dosing in Kidney Transplantation
    Kiberd, Bryce A.
    Lawen, Joseph
    Daley, Christopher
    THERAPEUTIC DRUG MONITORING, 2012, 34 (06) : 736 - 738
  • [42] Limits to Intensified Dosing of Mycophenolate Mofetil in Kidney Transplantation
    Kiberd, B.
    Daley, C.
    TRANSPLANTATION, 2012, 94 (10) : 328 - 328
  • [43] Mycophenolate mofetil - Suggested guidelines for use in kidney transplantation
    Behrend, M
    BIODRUGS, 2001, 15 (01) : 37 - 53
  • [44] Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation
    Cattaneo, D
    Perico, N
    Gaspari, F
    Gotti, E
    Remuzzi, G
    KIDNEY INTERNATIONAL, 2002, 62 (03) : 1060 - 1067
  • [45] Reduced BK virus nephropathy but increased acute rejection with mycophenolate mofetil dose reduction in kidney transplantation.
    Shaffer, D
    Langone, A
    Nylander, WA
    Kizilisik, AT
    Helderman, JH
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 199 - 199
  • [46] Changes of systemic and splanchnic circulation at six months after liver transplantation.
    Piscaglia, F
    Zironi, G
    Venturoli, N
    Grazi, GL
    Jovine, E
    Morganti, M
    Gaiani, S
    Valgimigli, M
    Mazziotti, A
    Cavallari, A
    Bolondi, L
    GASTROENTEROLOGY, 1996, 110 (04) : A1296 - A1296
  • [47] Sirolimus and mycophenolate mofetil after liver transplantation
    Kniepeiss, D
    Iberer, F
    Grasser, B
    Schaffellner, S
    Tschetiessnigg, KH
    TRANSPLANT INTERNATIONAL, 2003, 16 (07) : 504 - 509
  • [48] The influence of mycophenolate mofetil on the incidence and severity of cytomegalovirus prime-infections after renal transplantation.
    ter Meulen, CG
    Wetzels, JFM
    Hilbrands, LB
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2600 - 2600
  • [49] Comparative trial of Prograf (tacrolimus) in combination with azathioprine or mycophenolate mofetil vs. neoral (cyclosporine) with mycophenolate mofetil after kidney transplantation
    Gonwa, T
    Ahsan, N
    Halloran, P
    Stegall, M
    Hardy, M
    Metzger, R
    Shield, C
    Rocher, L
    Scandling, J
    Sorense, J
    Mulloy, L
    Light, J
    Corwin, C
    Danovitch, G
    Wachs, M
    Van Veldhuisen, P
    Salm, K
    Tolzman, D
    Fitzsimmons, W
    TRANSPLANTATION, 1999, 67 (07) : S239 - S239
  • [50] Intravenous mycophenolate mofetil plus prednisolone and cyclosporine in the prophylaxis of GvHD after stem cell transplantation.
    Kiehl, MG
    Armstrong, V
    Basara, N
    Blau, IW
    Oellerich, M
    Fauser, AA
    BLOOD, 1999, 94 (10) : 153A - 153A